SCHEMBL27200088

SCHEMBL27200088

COCCCOc1cc(O)c(Br)nc1OC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2B6 P20813 1/20 0.36
TENT4A Q5XG87 1/20 0.36
TENT4B Q8NDF8 1/20 0.36
KDM4E B2RXH2 3/20 0.33
USP2 O75604 1/20 0.33
RET P07949 1/20 0.33
KIF5B P33176 1/20 0.33
L3MBTL1 Q9Y468 5/20 0.33
MAPT P10636 4/20 0.33
HPGD P15428 3/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
EHMT2 Q96KQ7 1/20 0.32
KMT2A Q03164 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
ALDH1A1 P00352 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27200110 0.78 CYP2B6 (0.39) CYP2B6TENT4ATENT4BKDM4EUSP2
SCHEMBL31365216 0.78 CYP2B6 (0.39) CYP2B6TENT4ATENT4BKDM4EUSP2
SCHEMBL31365215 0.78 CYP2B6 (0.39) CYP2B6TENT4ATENT4BKDM4EUSP2
SCHEMBL26967891 0.74 PDPK1 (0.36) L3MBTL1
SCHEMBL27200131 0.73 CCR5 (0.42) NPC1RAB9ASMPD1
SCHEMBL21465027 0.73 HTR2A (0.35) CYP2B6TENT4ATENT4BCYP1A2LMNA
SCHEMBL22952875 0.73 HTR2A (0.35) CYP2B6TENT4ATENT4BCYP1A2LMNA
SCHEMBL21331710 0.73 MAPT (0.43) KDM4EUSP2RETKIF5BL3MBTL1
SCHEMBL611267 0.73 PIK3CA (0.36) CYP2B6TENT4ATENT4BKDM4EUSP2
SCHEMBL27200114 0.73 RET (0.34) CYP2B6TENT4ATENT4BKDM4EUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025008288-A1 9-OXO-9,10-DIHYDRO-6H-PYRANO[3,2-B:4,5-B']DIPYRIDINE-8-CARBOXYLIC ACID DERIVATIVES CENTENARA LABS AG (CH) 2025-01-09 WO disclosed
US-11964986-B1 9-oxo-9,10-dihydro-6H-pyrano[3,2-b:4,5-b′]dipyridine-8-carboxylic acid derivatives REJUVERON TELOMERE THERAPEUTICS AG (CH) 2024-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11964986-B1 9-oxo-9,10-dihydro-6H-pyrano[3,2-b:4,5-b′]dipyridine-8-carboxylic acid derivatives DPP9, DPYD, QDPR CYP2B6 26/4885TENT4A 2925/4885TENT4B 2915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.